ICD-10 Coding for Monoclonal Paraproteinemia(C90.0, C90.0P, D47.2)
Learn about ICD-10 coding for monoclonal paraproteinemia, including MGUS. Understand documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Monoclonal Paraproteinemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.2 | Monoclonal gammopathy | Use for asymptomatic monoclonal gammopathy without CRAB features. |
|
| G63.1 | Polyneuropathy in neoplastic disease | Use when neuropathy is directly linked to monoclonal gammopathy. |
|
| N28.9 | Disorder of kidney and ureter, unspecified | Use for renal involvement in monoclonal gammopathy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMonoclonal Paraproteinemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Monoclonal Paraproteinemia.
Documenting 'elevated paraprotein' without specifics.
Impact
Clinical: Inadequate clinical assessment., Regulatory: Potential coding errors., Financial: Incorrect reimbursement.
Mitigation
Always specify paraprotein type and level., Link symptoms to specific paraprotein findings.
Incorrectly coding MGRS as multiple myeloma.
Impact
Reimbursement: Incorrect DRG assignment., Compliance: Potential audit trigger., Data Quality: Inaccurate clinical data.
Mitigation
Use D47.2 + N28.9 unless CRAB criteria are met.
Incorrect coding of MGUS as multiple myeloma.
Impact
Coding MGUS as multiple myeloma without CRAB criteria.
Mitigation
Ensure documentation of CRAB criteria before coding as multiple myeloma.